nodes	percent_of_prediction	percent_of_DWPC	metapath
Trazodone—ABCB1—kidney cancer	0.15	1	CbGaD
Trazodone—CYP3A7—Temsirolimus—kidney cancer	0.0497	0.0757	CbGbCtD
Trazodone—CYP3A7-CYP3A51P—Temsirolimus—kidney cancer	0.0497	0.0757	CbGbCtD
Trazodone—ORM1—Erlotinib—kidney cancer	0.0413	0.063	CbGbCtD
Trazodone—CYP3A5—Temsirolimus—kidney cancer	0.0373	0.0568	CbGbCtD
Trazodone—HTR2B—Sorafenib—kidney cancer	0.0357	0.0544	CbGbCtD
Trazodone—ABCB1—Temsirolimus—kidney cancer	0.0243	0.037	CbGbCtD
Trazodone—HTR2C—Sorafenib—kidney cancer	0.0232	0.0354	CbGbCtD
Trazodone—CYP2D6—Temsirolimus—kidney cancer	0.0229	0.0348	CbGbCtD
Trazodone—CYP3A4—Everolimus—kidney cancer	0.0215	0.0328	CbGbCtD
Trazodone—CYP3A7—Paclitaxel—kidney cancer	0.0171	0.026	CbGbCtD
Trazodone—CYP3A7-CYP3A51P—Paclitaxel—kidney cancer	0.0171	0.026	CbGbCtD
Trazodone—CYP3A7—Sorafenib—kidney cancer	0.0151	0.0231	CbGbCtD
Trazodone—CYP3A7-CYP3A51P—Sorafenib—kidney cancer	0.0151	0.0231	CbGbCtD
Trazodone—CYP3A7-CYP3A51P—Vincristine—kidney cancer	0.0147	0.0224	CbGbCtD
Trazodone—CYP3A7—Vincristine—kidney cancer	0.0147	0.0224	CbGbCtD
Trazodone—CYP3A4—Temsirolimus—kidney cancer	0.0145	0.0221	CbGbCtD
Trazodone—CYP3A5—Erlotinib—kidney cancer	0.014	0.0213	CbGbCtD
Trazodone—CYP3A5—Paclitaxel—kidney cancer	0.0128	0.0195	CbGbCtD
Trazodone—ABCB1—Pazopanib—kidney cancer	0.0127	0.0194	CbGbCtD
Trazodone—CYP3A7-CYP3A51P—Sunitinib—kidney cancer	0.0123	0.0187	CbGbCtD
Trazodone—CYP3A7—Sunitinib—kidney cancer	0.0123	0.0187	CbGbCtD
Trazodone—CYP2D6—Pazopanib—kidney cancer	0.012	0.0183	CbGbCtD
Trazodone—ABCB1—Dactinomycin—kidney cancer	0.0117	0.0178	CbGbCtD
Trazodone—CYP3A5—Sorafenib—kidney cancer	0.0114	0.0173	CbGbCtD
Trazodone—CYP3A5—Vincristine—kidney cancer	0.011	0.0168	CbGbCtD
Trazodone—ABCB1—Gemcitabine—kidney cancer	0.00921	0.014	CbGbCtD
Trazodone—CYP3A5—Sunitinib—kidney cancer	0.0092	0.014	CbGbCtD
Trazodone—ABCB1—Erlotinib—kidney cancer	0.00909	0.0139	CbGbCtD
Trazodone—CYP2D6—Erlotinib—kidney cancer	0.00857	0.0131	CbGbCtD
Trazodone—ABCB1—Paclitaxel—kidney cancer	0.00832	0.0127	CbGbCtD
Trazodone—CYP3A4—Pazopanib—kidney cancer	0.00764	0.0116	CbGbCtD
Trazodone—ABCB1—Sorafenib—kidney cancer	0.00739	0.0113	CbGbCtD
Trazodone—ABCB1—Vinblastine—kidney cancer	0.0073	0.0111	CbGbCtD
Trazodone—ABCB1—Vincristine—kidney cancer	0.00718	0.0109	CbGbCtD
Trazodone—CYP2D6—Sorafenib—kidney cancer	0.00697	0.0106	CbGbCtD
Trazodone—CYP2D6—Vinblastine—kidney cancer	0.00688	0.0105	CbGbCtD
Trazodone—ABCB1—Sunitinib—kidney cancer	0.00599	0.00913	CbGbCtD
Trazodone—CYP3A4—Erlotinib—kidney cancer	0.00545	0.0083	CbGbCtD
Trazodone—CYP3A4—Paclitaxel—kidney cancer	0.00499	0.0076	CbGbCtD
Trazodone—ABCB1—Doxorubicin—kidney cancer	0.00449	0.00683	CbGbCtD
Trazodone—CYP3A4—Sorafenib—kidney cancer	0.00443	0.00675	CbGbCtD
Trazodone—CYP3A4—Vinblastine—kidney cancer	0.00437	0.00666	CbGbCtD
Trazodone—CYP3A4—Vincristine—kidney cancer	0.0043	0.00655	CbGbCtD
Trazodone—CYP2D6—Doxorubicin—kidney cancer	0.00423	0.00644	CbGbCtD
Trazodone—CYP3A4—Sunitinib—kidney cancer	0.00359	0.00547	CbGbCtD
Trazodone—CYP3A4—Doxorubicin—kidney cancer	0.00269	0.0041	CbGbCtD
Trazodone—HTR2A—urine—kidney cancer	0.000385	0.101	CbGeAlD
Trazodone—CYP3A4—urine—kidney cancer	0.000356	0.0934	CbGeAlD
Trazodone—CYP2D6—urine—kidney cancer	0.000351	0.0919	CbGeAlD
Trazodone—CYP3A7-CYP3A51P—nephron tubule—kidney cancer	0.000309	0.0809	CbGeAlD
Trazodone—CYP3A7-CYP3A51P—cortex of kidney—kidney cancer	0.000264	0.0692	CbGeAlD
Trazodone—HTR2B—cortex of kidney—kidney cancer	0.000166	0.0435	CbGeAlD
Trazodone—HTR1A—renal system—kidney cancer	0.000158	0.0414	CbGeAlD
Trazodone—ADRA1A—renal system—kidney cancer	0.000146	0.0382	CbGeAlD
Trazodone—CYP3A5—nephron tubule—kidney cancer	0.000128	0.0335	CbGeAlD
Trazodone—Paraesthesia—Vincristine—kidney cancer	0.000126	0.000739	CcSEcCtD
Trazodone—Agitation—Paclitaxel—kidney cancer	0.000126	0.000736	CcSEcCtD
Trazodone—Rash—Everolimus—kidney cancer	0.000125	0.000735	CcSEcCtD
Trazodone—Dermatitis—Everolimus—kidney cancer	0.000125	0.000734	CcSEcCtD
Trazodone—Headache—Vinblastine—kidney cancer	0.000125	0.000733	CcSEcCtD
Trazodone—Headache—Everolimus—kidney cancer	0.000125	0.00073	CcSEcCtD
Trazodone—Hypotension—Gemcitabine—kidney cancer	0.000125	0.00073	CcSEcCtD
Trazodone—Body temperature increased—Dactinomycin—kidney cancer	0.000124	0.000728	CcSEcCtD
Trazodone—Abdominal pain—Dactinomycin—kidney cancer	0.000124	0.000728	CcSEcCtD
Trazodone—Visual impairment—Capecitabine—kidney cancer	0.000124	0.000728	CcSEcCtD
Trazodone—Asthenia—Sorafenib—kidney cancer	0.000124	0.000726	CcSEcCtD
Trazodone—Malaise—Paclitaxel—kidney cancer	0.000123	0.000722	CcSEcCtD
Trazodone—Vertigo—Paclitaxel—kidney cancer	0.000123	0.00072	CcSEcCtD
Trazodone—Syncope—Paclitaxel—kidney cancer	0.000123	0.000718	CcSEcCtD
Trazodone—Lethargy—Doxorubicin—kidney cancer	0.000123	0.000718	CcSEcCtD
Trazodone—Cerebrovascular accident—Doxorubicin—kidney cancer	0.000123	0.000718	CcSEcCtD
Trazodone—Hypersensitivity—Sunitinib—kidney cancer	0.000122	0.000717	CcSEcCtD
Trazodone—Decreased appetite—Vincristine—kidney cancer	0.000122	0.000716	CcSEcCtD
Trazodone—Pruritus—Sorafenib—kidney cancer	0.000122	0.000716	CcSEcCtD
Trazodone—Vomiting—Erlotinib—kidney cancer	0.000122	0.000715	CcSEcCtD
Trazodone—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.000121	0.000711	CcSEcCtD
Trazodone—Fatigue—Vincristine—kidney cancer	0.000121	0.00071	CcSEcCtD
Trazodone—Rash—Erlotinib—kidney cancer	0.000121	0.000709	CcSEcCtD
Trazodone—Dermatitis—Erlotinib—kidney cancer	0.000121	0.000708	CcSEcCtD
Trazodone—Palpitations—Paclitaxel—kidney cancer	0.000121	0.000708	CcSEcCtD
Trazodone—Hyponatraemia—Doxorubicin—kidney cancer	0.000121	0.000706	CcSEcCtD
Trazodone—Insomnia—Gemcitabine—kidney cancer	0.000121	0.000706	CcSEcCtD
Trazodone—Headache—Erlotinib—kidney cancer	0.00012	0.000704	CcSEcCtD
Trazodone—Tinnitus—Capecitabine—kidney cancer	0.00012	0.000704	CcSEcCtD
Trazodone—Loss of consciousness—Paclitaxel—kidney cancer	0.00012	0.000704	CcSEcCtD
Trazodone—Constipation—Vincristine—kidney cancer	0.00012	0.000704	CcSEcCtD
Trazodone—Pain—Vincristine—kidney cancer	0.00012	0.000704	CcSEcCtD
Trazodone—Diplopia—Doxorubicin—kidney cancer	0.00012	0.000704	CcSEcCtD
Trazodone—Paraesthesia—Gemcitabine—kidney cancer	0.00012	0.000701	CcSEcCtD
Trazodone—Flushing—Capecitabine—kidney cancer	0.00012	0.000701	CcSEcCtD
Trazodone—Asthenia—Sunitinib—kidney cancer	0.000119	0.000698	CcSEcCtD
Trazodone—Dyspnoea—Gemcitabine—kidney cancer	0.000119	0.000696	CcSEcCtD
Trazodone—Nausea—Vinblastine—kidney cancer	0.000119	0.000695	CcSEcCtD
Trazodone—Somnolence—Gemcitabine—kidney cancer	0.000119	0.000694	CcSEcCtD
Trazodone—Migraine—Doxorubicin—kidney cancer	0.000118	0.000693	CcSEcCtD
Trazodone—Nausea—Everolimus—kidney cancer	0.000118	0.000692	CcSEcCtD
Trazodone—Diarrhoea—Sorafenib—kidney cancer	0.000118	0.000692	CcSEcCtD
Trazodone—Hypertension—Paclitaxel—kidney cancer	0.000118	0.000692	CcSEcCtD
Trazodone—Pruritus—Sunitinib—kidney cancer	0.000118	0.000689	CcSEcCtD
Trazodone—Chest pain—Paclitaxel—kidney cancer	0.000116	0.000682	CcSEcCtD
Trazodone—Myalgia—Paclitaxel—kidney cancer	0.000116	0.000682	CcSEcCtD
Trazodone—Arthralgia—Paclitaxel—kidney cancer	0.000116	0.000682	CcSEcCtD
Trazodone—CYP3A5—renal system—kidney cancer	0.000116	0.0304	CbGeAlD
Trazodone—Anxiety—Paclitaxel—kidney cancer	0.000116	0.00068	CcSEcCtD
Trazodone—Decreased appetite—Gemcitabine—kidney cancer	0.000116	0.000679	CcSEcCtD
Trazodone—Hypersensitivity—Dactinomycin—kidney cancer	0.000116	0.000679	CcSEcCtD
Trazodone—Chills—Capecitabine—kidney cancer	0.000116	0.000678	CcSEcCtD
Trazodone—Arrhythmia—Capecitabine—kidney cancer	0.000115	0.000675	CcSEcCtD
Trazodone—Discomfort—Paclitaxel—kidney cancer	0.000115	0.000674	CcSEcCtD
Trazodone—Fatigue—Gemcitabine—kidney cancer	0.000115	0.000673	CcSEcCtD
Trazodone—Gastrointestinal pain—Vincristine—kidney cancer	0.000115	0.000673	CcSEcCtD
Trazodone—Cardiac arrest—Doxorubicin—kidney cancer	0.000114	0.000669	CcSEcCtD
Trazodone—Dizziness—Sorafenib—kidney cancer	0.000114	0.000669	CcSEcCtD
Trazodone—Constipation—Gemcitabine—kidney cancer	0.000114	0.000668	CcSEcCtD
Trazodone—Pain—Gemcitabine—kidney cancer	0.000114	0.000668	CcSEcCtD
Trazodone—Nausea—Erlotinib—kidney cancer	0.000114	0.000668	CcSEcCtD
Trazodone—Alopecia—Capecitabine—kidney cancer	0.000114	0.000667	CcSEcCtD
Trazodone—Dry mouth—Paclitaxel—kidney cancer	0.000114	0.000667	CcSEcCtD
Trazodone—Diarrhoea—Sunitinib—kidney cancer	0.000114	0.000666	CcSEcCtD
Trazodone—Ataxia—Doxorubicin—kidney cancer	0.000113	0.000662	CcSEcCtD
Trazodone—Asthenia—Dactinomycin—kidney cancer	0.000113	0.000661	CcSEcCtD
Trazodone—Confusional state—Paclitaxel—kidney cancer	0.000113	0.000659	CcSEcCtD
Trazodone—CYP3A5—kidney—kidney cancer	0.000112	0.0294	CbGeAlD
Trazodone—Oedema—Paclitaxel—kidney cancer	0.000112	0.000654	CcSEcCtD
Trazodone—Body temperature increased—Vincristine—kidney cancer	0.000111	0.000651	CcSEcCtD
Trazodone—Abdominal pain—Vincristine—kidney cancer	0.000111	0.000651	CcSEcCtD
Trazodone—Flatulence—Capecitabine—kidney cancer	0.000111	0.000648	CcSEcCtD
Trazodone—Dysgeusia—Capecitabine—kidney cancer	0.00011	0.000644	CcSEcCtD
Trazodone—Dizziness—Sunitinib—kidney cancer	0.00011	0.000644	CcSEcCtD
Trazodone—Feeling abnormal—Gemcitabine—kidney cancer	0.00011	0.000643	CcSEcCtD
Trazodone—Shock—Paclitaxel—kidney cancer	0.00011	0.000643	CcSEcCtD
Trazodone—Vomiting—Sorafenib—kidney cancer	0.00011	0.000643	CcSEcCtD
Trazodone—Orthostatic hypotension—Doxorubicin—kidney cancer	0.00011	0.000643	CcSEcCtD
Trazodone—CYP3A5—cortex of kidney—kidney cancer	0.000109	0.0287	CbGeAlD
Trazodone—Tachycardia—Paclitaxel—kidney cancer	0.000109	0.000638	CcSEcCtD
Trazodone—Rash—Sorafenib—kidney cancer	0.000109	0.000638	CcSEcCtD
Trazodone—Dermatitis—Sorafenib—kidney cancer	0.000109	0.000637	CcSEcCtD
Trazodone—Back pain—Capecitabine—kidney cancer	0.000109	0.000636	CcSEcCtD
Trazodone—Headache—Sorafenib—kidney cancer	0.000108	0.000634	CcSEcCtD
Trazodone—Hyperhidrosis—Paclitaxel—kidney cancer	0.000108	0.000632	CcSEcCtD
Trazodone—Diarrhoea—Dactinomycin—kidney cancer	0.000108	0.00063	CcSEcCtD
Trazodone—Anorexia—Paclitaxel—kidney cancer	0.000106	0.000623	CcSEcCtD
Trazodone—Vision blurred—Capecitabine—kidney cancer	0.000106	0.00062	CcSEcCtD
Trazodone—Vomiting—Sunitinib—kidney cancer	0.000106	0.000619	CcSEcCtD
Trazodone—Body temperature increased—Gemcitabine—kidney cancer	0.000105	0.000617	CcSEcCtD
Trazodone—Tremor—Capecitabine—kidney cancer	0.000105	0.000616	CcSEcCtD
Trazodone—Rash—Sunitinib—kidney cancer	0.000105	0.000614	CcSEcCtD
Trazodone—Dermatitis—Sunitinib—kidney cancer	0.000105	0.000613	CcSEcCtD
Trazodone—ADRA2A—cortex of kidney—kidney cancer	0.000104	0.0273	CbGeAlD
Trazodone—Hypotension—Paclitaxel—kidney cancer	0.000104	0.000611	CcSEcCtD
Trazodone—Ill-defined disorder—Capecitabine—kidney cancer	0.000104	0.00061	CcSEcCtD
Trazodone—Headache—Sunitinib—kidney cancer	0.000104	0.00061	CcSEcCtD
Trazodone—Anaemia—Capecitabine—kidney cancer	0.000104	0.000608	CcSEcCtD
Trazodone—Hypersensitivity—Vincristine—kidney cancer	0.000104	0.000606	CcSEcCtD
Trazodone—Nausea—Sorafenib—kidney cancer	0.000103	0.000601	CcSEcCtD
Trazodone—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000102	0.000596	CcSEcCtD
Trazodone—Malaise—Capecitabine—kidney cancer	0.000101	0.000593	CcSEcCtD
Trazodone—Insomnia—Paclitaxel—kidney cancer	0.000101	0.000591	CcSEcCtD
Trazodone—Vertigo—Capecitabine—kidney cancer	0.000101	0.000591	CcSEcCtD
Trazodone—Asthenia—Vincristine—kidney cancer	0.000101	0.000591	CcSEcCtD
Trazodone—Syncope—Capecitabine—kidney cancer	0.000101	0.00059	CcSEcCtD
Trazodone—Paraesthesia—Paclitaxel—kidney cancer	0.0001	0.000587	CcSEcCtD
Trazodone—Vomiting—Dactinomycin—kidney cancer	0.0001	0.000586	CcSEcCtD
Trazodone—Dyspnoea—Paclitaxel—kidney cancer	9.95e-05	0.000583	CcSEcCtD
Trazodone—ADRA2A—gonad—kidney cancer	9.94e-05	0.026	CbGeAlD
Trazodone—Somnolence—Paclitaxel—kidney cancer	9.92e-05	0.000581	CcSEcCtD
Trazodone—ADRA2A—cardiac atrium—kidney cancer	9.92e-05	0.026	CbGeAlD
Trazodone—Palpitations—Capecitabine—kidney cancer	9.92e-05	0.000581	CcSEcCtD
Trazodone—Rash—Dactinomycin—kidney cancer	9.92e-05	0.000581	CcSEcCtD
Trazodone—Nausea—Sunitinib—kidney cancer	9.87e-05	0.000578	CcSEcCtD
Trazodone—Loss of consciousness—Capecitabine—kidney cancer	9.86e-05	0.000578	CcSEcCtD
Trazodone—Decreased appetite—Paclitaxel—kidney cancer	9.7e-05	0.000568	CcSEcCtD
Trazodone—Hypertension—Capecitabine—kidney cancer	9.69e-05	0.000568	CcSEcCtD
Trazodone—Fatigue—Paclitaxel—kidney cancer	9.62e-05	0.000564	CcSEcCtD
Trazodone—Diarrhoea—Vincristine—kidney cancer	9.61e-05	0.000563	CcSEcCtD
Trazodone—Pollakiuria—Doxorubicin—kidney cancer	9.59e-05	0.000562	CcSEcCtD
Trazodone—Asthenia—Gemcitabine—kidney cancer	9.56e-05	0.00056	CcSEcCtD
Trazodone—Arthralgia—Capecitabine—kidney cancer	9.55e-05	0.00056	CcSEcCtD
Trazodone—Myalgia—Capecitabine—kidney cancer	9.55e-05	0.00056	CcSEcCtD
Trazodone—Chest pain—Capecitabine—kidney cancer	9.55e-05	0.00056	CcSEcCtD
Trazodone—Pain—Paclitaxel—kidney cancer	9.54e-05	0.000559	CcSEcCtD
Trazodone—Constipation—Paclitaxel—kidney cancer	9.54e-05	0.000559	CcSEcCtD
Trazodone—Anxiety—Capecitabine—kidney cancer	9.52e-05	0.000558	CcSEcCtD
Trazodone—Photosensitivity reaction—Doxorubicin—kidney cancer	9.48e-05	0.000555	CcSEcCtD
Trazodone—Weight increased—Doxorubicin—kidney cancer	9.45e-05	0.000553	CcSEcCtD
Trazodone—Discomfort—Capecitabine—kidney cancer	9.44e-05	0.000553	CcSEcCtD
Trazodone—Pruritus—Gemcitabine—kidney cancer	9.43e-05	0.000552	CcSEcCtD
Trazodone—HTR2A—renal system—kidney cancer	9.42e-05	0.0247	CbGeAlD
Trazodone—Weight decreased—Doxorubicin—kidney cancer	9.39e-05	0.00055	CcSEcCtD
Trazodone—Dry mouth—Capecitabine—kidney cancer	9.34e-05	0.000547	CcSEcCtD
Trazodone—Nausea—Dactinomycin—kidney cancer	9.34e-05	0.000547	CcSEcCtD
Trazodone—Dizziness—Vincristine—kidney cancer	9.29e-05	0.000544	CcSEcCtD
Trazodone—Drowsiness—Doxorubicin—kidney cancer	9.26e-05	0.000542	CcSEcCtD
Trazodone—Confusional state—Capecitabine—kidney cancer	9.24e-05	0.000541	CcSEcCtD
Trazodone—Feeling abnormal—Paclitaxel—kidney cancer	9.2e-05	0.000539	CcSEcCtD
Trazodone—Oedema—Capecitabine—kidney cancer	9.16e-05	0.000537	CcSEcCtD
Trazodone—Gastrointestinal pain—Paclitaxel—kidney cancer	9.13e-05	0.000535	CcSEcCtD
Trazodone—Diarrhoea—Gemcitabine—kidney cancer	9.12e-05	0.000534	CcSEcCtD
Trazodone—HTR2A—kidney—kidney cancer	9.11e-05	0.0239	CbGeAlD
Trazodone—Jaundice—Doxorubicin—kidney cancer	9.02e-05	0.000529	CcSEcCtD
Trazodone—Shock—Capecitabine—kidney cancer	9.01e-05	0.000528	CcSEcCtD
Trazodone—Tachycardia—Capecitabine—kidney cancer	8.94e-05	0.000524	CcSEcCtD
Trazodone—Vomiting—Vincristine—kidney cancer	8.93e-05	0.000523	CcSEcCtD
Trazodone—Sweating—Doxorubicin—kidney cancer	8.87e-05	0.00052	CcSEcCtD
Trazodone—Urticaria—Paclitaxel—kidney cancer	8.87e-05	0.000519	CcSEcCtD
Trazodone—Rash—Vincristine—kidney cancer	8.86e-05	0.000519	CcSEcCtD
Trazodone—Hyperhidrosis—Capecitabine—kidney cancer	8.85e-05	0.000519	CcSEcCtD
Trazodone—Dermatitis—Vincristine—kidney cancer	8.85e-05	0.000519	CcSEcCtD
Trazodone—Haematuria—Doxorubicin—kidney cancer	8.83e-05	0.000517	CcSEcCtD
Trazodone—Body temperature increased—Paclitaxel—kidney cancer	8.82e-05	0.000517	CcSEcCtD
Trazodone—Abdominal pain—Paclitaxel—kidney cancer	8.82e-05	0.000517	CcSEcCtD
Trazodone—Headache—Vincristine—kidney cancer	8.8e-05	0.000516	CcSEcCtD
Trazodone—Anorexia—Capecitabine—kidney cancer	8.73e-05	0.000511	CcSEcCtD
Trazodone—CYP3A4—renal system—kidney cancer	8.72e-05	0.0228	CbGeAlD
Trazodone—CYP2D6—renal system—kidney cancer	8.58e-05	0.0225	CbGeAlD
Trazodone—Hypotension—Capecitabine—kidney cancer	8.56e-05	0.000501	CcSEcCtD
Trazodone—Vomiting—Gemcitabine—kidney cancer	8.48e-05	0.000496	CcSEcCtD
Trazodone—Bradycardia—Doxorubicin—kidney cancer	8.46e-05	0.000496	CcSEcCtD
Trazodone—HTR2A—gonad—kidney cancer	8.45e-05	0.0221	CbGeAlD
Trazodone—CYP3A4—kidney—kidney cancer	8.43e-05	0.0221	CbGeAlD
Trazodone—Rash—Gemcitabine—kidney cancer	8.41e-05	0.000492	CcSEcCtD
Trazodone—Dermatitis—Gemcitabine—kidney cancer	8.4e-05	0.000492	CcSEcCtD
Trazodone—Headache—Gemcitabine—kidney cancer	8.35e-05	0.000489	CcSEcCtD
Trazodone—Nausea—Vincristine—kidney cancer	8.35e-05	0.000489	CcSEcCtD
Trazodone—Musculoskeletal discomfort—Capecitabine—kidney cancer	8.34e-05	0.000489	CcSEcCtD
Trazodone—CYP2D6—kidney—kidney cancer	8.3e-05	0.0217	CbGeAlD
Trazodone—Insomnia—Capecitabine—kidney cancer	8.28e-05	0.000485	CcSEcCtD
Trazodone—Hypoaesthesia—Doxorubicin—kidney cancer	8.27e-05	0.000484	CcSEcCtD
Trazodone—Paraesthesia—Capecitabine—kidney cancer	8.22e-05	0.000482	CcSEcCtD
Trazodone—Hypersensitivity—Paclitaxel—kidney cancer	8.22e-05	0.000482	CcSEcCtD
Trazodone—Dyspnoea—Capecitabine—kidney cancer	8.17e-05	0.000478	CcSEcCtD
Trazodone—Visual impairment—Doxorubicin—kidney cancer	8.01e-05	0.000469	CcSEcCtD
Trazodone—Asthenia—Paclitaxel—kidney cancer	8.01e-05	0.000469	CcSEcCtD
Trazodone—Decreased appetite—Capecitabine—kidney cancer	7.96e-05	0.000466	CcSEcCtD
Trazodone—Nausea—Gemcitabine—kidney cancer	7.92e-05	0.000464	CcSEcCtD
Trazodone—Fatigue—Capecitabine—kidney cancer	7.9e-05	0.000463	CcSEcCtD
Trazodone—Pruritus—Paclitaxel—kidney cancer	7.9e-05	0.000463	CcSEcCtD
Trazodone—Pain—Capecitabine—kidney cancer	7.83e-05	0.000459	CcSEcCtD
Trazodone—Constipation—Capecitabine—kidney cancer	7.83e-05	0.000459	CcSEcCtD
Trazodone—Tinnitus—Doxorubicin—kidney cancer	7.75e-05	0.000454	CcSEcCtD
Trazodone—Flushing—Doxorubicin—kidney cancer	7.71e-05	0.000452	CcSEcCtD
Trazodone—Diarrhoea—Paclitaxel—kidney cancer	7.64e-05	0.000447	CcSEcCtD
Trazodone—Feeling abnormal—Capecitabine—kidney cancer	7.55e-05	0.000442	CcSEcCtD
Trazodone—Gastrointestinal pain—Capecitabine—kidney cancer	7.49e-05	0.000439	CcSEcCtD
Trazodone—Chills—Doxorubicin—kidney cancer	7.46e-05	0.000437	CcSEcCtD
Trazodone—Arrhythmia—Doxorubicin—kidney cancer	7.42e-05	0.000435	CcSEcCtD
Trazodone—Dizziness—Paclitaxel—kidney cancer	7.38e-05	0.000432	CcSEcCtD
Trazodone—Alopecia—Doxorubicin—kidney cancer	7.34e-05	0.00043	CcSEcCtD
Trazodone—Urticaria—Capecitabine—kidney cancer	7.28e-05	0.000426	CcSEcCtD
Trazodone—Abdominal pain—Capecitabine—kidney cancer	7.24e-05	0.000424	CcSEcCtD
Trazodone—Body temperature increased—Capecitabine—kidney cancer	7.24e-05	0.000424	CcSEcCtD
Trazodone—Flatulence—Doxorubicin—kidney cancer	7.13e-05	0.000418	CcSEcCtD
Trazodone—Tension—Doxorubicin—kidney cancer	7.1e-05	0.000416	CcSEcCtD
Trazodone—Vomiting—Paclitaxel—kidney cancer	7.1e-05	0.000416	CcSEcCtD
Trazodone—Dysgeusia—Doxorubicin—kidney cancer	7.08e-05	0.000415	CcSEcCtD
Trazodone—Rash—Paclitaxel—kidney cancer	7.04e-05	0.000412	CcSEcCtD
Trazodone—Dermatitis—Paclitaxel—kidney cancer	7.03e-05	0.000412	CcSEcCtD
Trazodone—Nervousness—Doxorubicin—kidney cancer	7.03e-05	0.000412	CcSEcCtD
Trazodone—Back pain—Doxorubicin—kidney cancer	7e-05	0.00041	CcSEcCtD
Trazodone—Headache—Paclitaxel—kidney cancer	6.99e-05	0.00041	CcSEcCtD
Trazodone—Vision blurred—Doxorubicin—kidney cancer	6.82e-05	0.000399	CcSEcCtD
Trazodone—ABCB1—nephron tubule—kidney cancer	6.79e-05	0.0178	CbGeAlD
Trazodone—Hypersensitivity—Capecitabine—kidney cancer	6.75e-05	0.000395	CcSEcCtD
Trazodone—Domperidone—ABCB1—kidney cancer	6.73e-05	0.185	CrCbGaD
Trazodone—Ill-defined disorder—Doxorubicin—kidney cancer	6.71e-05	0.000393	CcSEcCtD
Trazodone—Anaemia—Doxorubicin—kidney cancer	6.69e-05	0.000392	CcSEcCtD
Trazodone—Agitation—Doxorubicin—kidney cancer	6.65e-05	0.000389	CcSEcCtD
Trazodone—Nausea—Paclitaxel—kidney cancer	6.63e-05	0.000388	CcSEcCtD
Trazodone—Asthenia—Capecitabine—kidney cancer	6.57e-05	0.000385	CcSEcCtD
Trazodone—Malaise—Doxorubicin—kidney cancer	6.52e-05	0.000382	CcSEcCtD
Trazodone—Vertigo—Doxorubicin—kidney cancer	6.5e-05	0.000381	CcSEcCtD
Trazodone—Syncope—Doxorubicin—kidney cancer	6.49e-05	0.00038	CcSEcCtD
Trazodone—Pruritus—Capecitabine—kidney cancer	6.48e-05	0.00038	CcSEcCtD
Trazodone—Palpitations—Doxorubicin—kidney cancer	6.39e-05	0.000374	CcSEcCtD
Trazodone—Loss of consciousness—Doxorubicin—kidney cancer	6.36e-05	0.000372	CcSEcCtD
Trazodone—Diarrhoea—Capecitabine—kidney cancer	6.27e-05	0.000367	CcSEcCtD
Trazodone—Hypertension—Doxorubicin—kidney cancer	6.25e-05	0.000366	CcSEcCtD
Trazodone—ABCB1—renal system—kidney cancer	6.17e-05	0.0162	CbGeAlD
Trazodone—Myalgia—Doxorubicin—kidney cancer	6.16e-05	0.000361	CcSEcCtD
Trazodone—Chest pain—Doxorubicin—kidney cancer	6.16e-05	0.000361	CcSEcCtD
Trazodone—Arthralgia—Doxorubicin—kidney cancer	6.16e-05	0.000361	CcSEcCtD
Trazodone—Anxiety—Doxorubicin—kidney cancer	6.14e-05	0.00036	CcSEcCtD
Trazodone—Discomfort—Doxorubicin—kidney cancer	6.09e-05	0.000356	CcSEcCtD
Trazodone—Dizziness—Capecitabine—kidney cancer	6.06e-05	0.000355	CcSEcCtD
Trazodone—Dry mouth—Doxorubicin—kidney cancer	6.02e-05	0.000353	CcSEcCtD
Trazodone—ABCB1—kidney—kidney cancer	5.97e-05	0.0156	CbGeAlD
Trazodone—Confusional state—Doxorubicin—kidney cancer	5.95e-05	0.000349	CcSEcCtD
Trazodone—Oedema—Doxorubicin—kidney cancer	5.9e-05	0.000346	CcSEcCtD
Trazodone—Vomiting—Capecitabine—kidney cancer	5.82e-05	0.000341	CcSEcCtD
Trazodone—ABCB1—cortex of kidney—kidney cancer	5.81e-05	0.0152	CbGeAlD
Trazodone—Shock—Doxorubicin—kidney cancer	5.81e-05	0.00034	CcSEcCtD
Trazodone—Rash—Capecitabine—kidney cancer	5.78e-05	0.000338	CcSEcCtD
Trazodone—Dermatitis—Capecitabine—kidney cancer	5.77e-05	0.000338	CcSEcCtD
Trazodone—Tachycardia—Doxorubicin—kidney cancer	5.76e-05	0.000338	CcSEcCtD
Trazodone—Headache—Capecitabine—kidney cancer	5.74e-05	0.000336	CcSEcCtD
Trazodone—Hyperhidrosis—Doxorubicin—kidney cancer	5.71e-05	0.000334	CcSEcCtD
Trazodone—Anorexia—Doxorubicin—kidney cancer	5.63e-05	0.00033	CcSEcCtD
Trazodone—Nefazodone—ABCB1—kidney cancer	5.59e-05	0.154	CrCbGaD
Trazodone—ABCB1—gonad—kidney cancer	5.54e-05	0.0145	CbGeAlD
Trazodone—Hypotension—Doxorubicin—kidney cancer	5.52e-05	0.000323	CcSEcCtD
Trazodone—Nausea—Capecitabine—kidney cancer	5.44e-05	0.000319	CcSEcCtD
Trazodone—Musculoskeletal discomfort—Doxorubicin—kidney cancer	5.38e-05	0.000315	CcSEcCtD
Trazodone—Insomnia—Doxorubicin—kidney cancer	5.34e-05	0.000313	CcSEcCtD
Trazodone—Paraesthesia—Doxorubicin—kidney cancer	5.3e-05	0.000311	CcSEcCtD
Trazodone—Dyspnoea—Doxorubicin—kidney cancer	5.26e-05	0.000308	CcSEcCtD
Trazodone—Clozapine—CYP1A1—kidney cancer	5.25e-05	0.145	CrCbGaD
Trazodone—Somnolence—Doxorubicin—kidney cancer	5.25e-05	0.000307	CcSEcCtD
Trazodone—Aripiprazole—ABCB1—kidney cancer	5.19e-05	0.143	CrCbGaD
Trazodone—Decreased appetite—Doxorubicin—kidney cancer	5.13e-05	0.000301	CcSEcCtD
Trazodone—Fatigue—Doxorubicin—kidney cancer	5.09e-05	0.000298	CcSEcCtD
Trazodone—Pain—Doxorubicin—kidney cancer	5.05e-05	0.000296	CcSEcCtD
Trazodone—Constipation—Doxorubicin—kidney cancer	5.05e-05	0.000296	CcSEcCtD
Trazodone—Feeling abnormal—Doxorubicin—kidney cancer	4.87e-05	0.000285	CcSEcCtD
Trazodone—Gastrointestinal pain—Doxorubicin—kidney cancer	4.83e-05	0.000283	CcSEcCtD
Trazodone—Urticaria—Doxorubicin—kidney cancer	4.69e-05	0.000275	CcSEcCtD
Trazodone—Abdominal pain—Doxorubicin—kidney cancer	4.67e-05	0.000273	CcSEcCtD
Trazodone—Body temperature increased—Doxorubicin—kidney cancer	4.67e-05	0.000273	CcSEcCtD
Trazodone—Hypersensitivity—Doxorubicin—kidney cancer	4.35e-05	0.000255	CcSEcCtD
Trazodone—Asthenia—Doxorubicin—kidney cancer	4.24e-05	0.000248	CcSEcCtD
Trazodone—Fluphenazine—ABCB1—kidney cancer	4.19e-05	0.115	CrCbGaD
Trazodone—Pruritus—Doxorubicin—kidney cancer	4.18e-05	0.000245	CcSEcCtD
Trazodone—Diarrhoea—Doxorubicin—kidney cancer	4.04e-05	0.000237	CcSEcCtD
Trazodone—Dizziness—Doxorubicin—kidney cancer	3.9e-05	0.000229	CcSEcCtD
Trazodone—Vomiting—Doxorubicin—kidney cancer	3.75e-05	0.00022	CcSEcCtD
Trazodone—Rash—Doxorubicin—kidney cancer	3.72e-05	0.000218	CcSEcCtD
Trazodone—Dermatitis—Doxorubicin—kidney cancer	3.72e-05	0.000218	CcSEcCtD
Trazodone—Headache—Doxorubicin—kidney cancer	3.7e-05	0.000217	CcSEcCtD
Trazodone—Nausea—Doxorubicin—kidney cancer	3.51e-05	0.000205	CcSEcCtD
Trazodone—Trifluoperazine—ABCB1—kidney cancer	3.35e-05	0.0921	CrCbGaD
Trazodone—Quetiapine—ABCB1—kidney cancer	3.25e-05	0.0893	CrCbGaD
Trazodone—Clozapine—ABCB1—kidney cancer	2.79e-05	0.0768	CrCbGaD
Trazodone—ADRA2A—Signaling Pathways—IGF2—kidney cancer	3.69e-06	0.000195	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—CDKN2B—kidney cancer	3.67e-06	0.000194	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—SLC5A5—kidney cancer	3.66e-06	0.000194	CbGpPWpGaD
Trazodone—ADRA1A—GPCR downstream signaling—IL2—kidney cancer	3.65e-06	0.000193	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—CYP1A1—kidney cancer	3.62e-06	0.000191	CbGpPWpGaD
Trazodone—ABCB1—Transmembrane transport of small molecules—RAF1—kidney cancer	3.58e-06	0.000189	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—KDR—kidney cancer	3.57e-06	0.000189	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—IGF1R—kidney cancer	3.56e-06	0.000188	CbGpPWpGaD
Trazodone—ADRA2A—Hemostasis—PIK3CA—kidney cancer	3.56e-06	0.000188	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—KDR—kidney cancer	3.55e-06	0.000188	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—SLC2A1—kidney cancer	3.54e-06	0.000187	CbGpPWpGaD
Trazodone—HTR2B—GPCR downstream signaling—PIK3CA—kidney cancer	3.53e-06	0.000187	CbGpPWpGaD
Trazodone—HTR2B—Signaling by GPCR—KRAS—kidney cancer	3.49e-06	0.000184	CbGpPWpGaD
Trazodone—ADRA2A—Hemostasis—TP53—kidney cancer	3.45e-06	0.000182	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—RAF1—kidney cancer	3.43e-06	0.000181	CbGpPWpGaD
Trazodone—ADRA2A—GPCR downstream signaling—IL2—kidney cancer	3.39e-06	0.000179	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—IL2—kidney cancer	3.38e-06	0.000179	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—IL2—kidney cancer	3.38e-06	0.000178	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—IL2—kidney cancer	3.31e-06	0.000175	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—APC—kidney cancer	3.29e-06	0.000174	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—KIT—kidney cancer	3.29e-06	0.000174	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—CRABP1—kidney cancer	3.28e-06	0.000173	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—APC—kidney cancer	3.27e-06	0.000173	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—KIT—kidney cancer	3.27e-06	0.000173	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—HIF1A—kidney cancer	3.22e-06	0.00017	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—HIF1A—kidney cancer	3.22e-06	0.00017	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—TSC2—kidney cancer	3.22e-06	0.00017	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—TSC2—kidney cancer	3.21e-06	0.00017	CbGpPWpGaD
Trazodone—HTR2B—Signaling by GPCR—PIK3CA—kidney cancer	3.21e-06	0.000169	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—RAF1—kidney cancer	3.18e-06	0.000168	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—RELA—kidney cancer	3.17e-06	0.000167	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—HIF1A—kidney cancer	3.16e-06	0.000167	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—TSC2—kidney cancer	3.15e-06	0.000166	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—MAPK3—kidney cancer	3.15e-06	0.000166	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—ERBB2—kidney cancer	3.15e-06	0.000166	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—MAPK3—kidney cancer	3.13e-06	0.000165	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—GSTP1—kidney cancer	3.13e-06	0.000165	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—POMC—kidney cancer	3.13e-06	0.000165	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—POMC—kidney cancer	3.11e-06	0.000164	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—MTOR—kidney cancer	3.11e-06	0.000164	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—BRAF—kidney cancer	3.09e-06	0.000163	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—KDR—kidney cancer	3.08e-06	0.000163	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—IL2—kidney cancer	3.08e-06	0.000163	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—KDR—kidney cancer	3.08e-06	0.000163	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—BRAF—kidney cancer	3.08e-06	0.000162	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—ITPR2—kidney cancer	3.05e-06	0.000161	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—KDR—kidney cancer	3.02e-06	0.00016	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—MAPK1—kidney cancer	3e-06	0.000158	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—MAPK1—kidney cancer	2.98e-06	0.000157	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—PTGS2—kidney cancer	2.98e-06	0.000157	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—GSTP1—kidney cancer	2.95e-06	0.000156	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—POMC—kidney cancer	2.94e-06	0.000155	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—HIF1A—kidney cancer	2.93e-06	0.000155	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—TSC2—kidney cancer	2.93e-06	0.000155	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—CDKN1B—kidney cancer	2.92e-06	0.000154	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—GSTM1—kidney cancer	2.88e-06	0.000152	CbGpPWpGaD
Trazodone—HTR1A—GPCR downstream signaling—PIK3CA—kidney cancer	2.86e-06	0.000151	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—IL2—kidney cancer	2.85e-06	0.000151	CbGpPWpGaD
Trazodone—HTR2C—GPCR downstream signaling—PIK3CA—kidney cancer	2.85e-06	0.00015	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—APC—kidney cancer	2.84e-06	0.00015	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—KIT—kidney cancer	2.84e-06	0.00015	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—APC—kidney cancer	2.83e-06	0.00015	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—KIT—kidney cancer	2.83e-06	0.00015	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—KRAS—kidney cancer	2.83e-06	0.000149	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—KRAS—kidney cancer	2.82e-06	0.000149	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—KDR—kidney cancer	2.81e-06	0.000148	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—ABCB1—kidney cancer	2.79e-06	0.000148	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—ACHE—kidney cancer	2.78e-06	0.000147	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—GSTT1—kidney cancer	2.78e-06	0.000147	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—CCND1—kidney cancer	2.78e-06	0.000147	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—APC—kidney cancer	2.78e-06	0.000147	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—KIT—kidney cancer	2.78e-06	0.000147	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—JUN—kidney cancer	2.78e-06	0.000147	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—CTNNB1—kidney cancer	2.75e-06	0.000146	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—CYP1A1—kidney cancer	2.73e-06	0.000144	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—MAPK3—kidney cancer	2.72e-06	0.000144	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—MAPK3—kidney cancer	2.71e-06	0.000143	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—GSTM1—kidney cancer	2.71e-06	0.000143	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—POMC—kidney cancer	2.7e-06	0.000143	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—POMC—kidney cancer	2.7e-06	0.000143	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—POMC—kidney cancer	2.7e-06	0.000142	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—PTEN—kidney cancer	2.69e-06	0.000142	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—BRAF—kidney cancer	2.67e-06	0.000141	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—BRAF—kidney cancer	2.66e-06	0.000141	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—MAPK3—kidney cancer	2.66e-06	0.000141	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—POMC—kidney cancer	2.65e-06	0.00014	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—SCARB1—kidney cancer	2.64e-06	0.000139	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—BRAF—kidney cancer	2.61e-06	0.000138	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—PTGS1—kidney cancer	2.61e-06	0.000138	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—PIK3CA—kidney cancer	2.6e-06	0.000137	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—PTEN—kidney cancer	2.59e-06	0.000137	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—MAPK1—kidney cancer	2.59e-06	0.000137	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—PIK3CA—kidney cancer	2.59e-06	0.000137	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—KIT—kidney cancer	2.58e-06	0.000137	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—APC—kidney cancer	2.58e-06	0.000137	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—MAPK1—kidney cancer	2.58e-06	0.000136	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—RAF1—kidney cancer	2.58e-06	0.000136	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—CYP1A1—kidney cancer	2.57e-06	0.000136	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—RELA—kidney cancer	2.57e-06	0.000136	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—RAF1—kidney cancer	2.57e-06	0.000136	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—PSMD7—kidney cancer	2.56e-06	0.000135	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—RELA—kidney cancer	2.56e-06	0.000135	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—ERBB2—kidney cancer	2.55e-06	0.000135	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—ERBB2—kidney cancer	2.54e-06	0.000134	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—MAPK1—kidney cancer	2.53e-06	0.000134	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—MTOR—kidney cancer	2.52e-06	0.000133	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—MTOR—kidney cancer	2.51e-06	0.000132	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—MAPK3—kidney cancer	2.48e-06	0.000131	CbGpPWpGaD
Trazodone—HTR2A—GPCR downstream signaling—PIK3CA—kidney cancer	2.47e-06	0.000131	CbGpPWpGaD
Trazodone—HRH1—GPCR downstream signaling—PIK3CA—kidney cancer	2.47e-06	0.00013	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—POMC—kidney cancer	2.46e-06	0.00013	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—KRAS—kidney cancer	2.45e-06	0.000129	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—KRAS—kidney cancer	2.44e-06	0.000129	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—BRAF—kidney cancer	2.43e-06	0.000128	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—BCHE—kidney cancer	2.43e-06	0.000128	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—VEGFA—kidney cancer	2.43e-06	0.000128	CbGpPWpGaD
Trazodone—ADRA1A—GPCR downstream signaling—PIK3CA—kidney cancer	2.42e-06	0.000128	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—SLC5A5—kidney cancer	2.4e-06	0.000127	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—KRAS—kidney cancer	2.39e-06	0.000126	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—CDKN1B—kidney cancer	2.36e-06	0.000125	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—MAPK1—kidney cancer	2.36e-06	0.000124	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—CDKN1B—kidney cancer	2.35e-06	0.000124	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—PTGS2—kidney cancer	2.35e-06	0.000124	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—IL2—kidney cancer	2.31e-06	0.000122	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—SLC2A1—kidney cancer	2.31e-06	0.000122	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—IL2—kidney cancer	2.3e-06	0.000122	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—MAPK3—kidney cancer	2.29e-06	0.000121	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—CCND1—kidney cancer	2.26e-06	0.000119	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—JUN—kidney cancer	2.25e-06	0.000119	CbGpPWpGaD
Trazodone—ADRA2A—GPCR downstream signaling—PIK3CA—kidney cancer	2.25e-06	0.000119	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—PIK3CA—kidney cancer	2.25e-06	0.000119	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—CCND1—kidney cancer	2.24e-06	0.000119	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—PIK3CA—kidney cancer	2.24e-06	0.000118	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—JUN—kidney cancer	2.24e-06	0.000118	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—CTNNB1—kidney cancer	2.23e-06	0.000118	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—MYC—kidney cancer	2.23e-06	0.000118	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—RAF1—kidney cancer	2.23e-06	0.000118	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—RAF1—kidney cancer	2.22e-06	0.000118	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—KRAS—kidney cancer	2.22e-06	0.000118	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—CTNNB1—kidney cancer	2.22e-06	0.000117	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—RELA—kidney cancer	2.22e-06	0.000117	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—RELA—kidney cancer	2.22e-06	0.000117	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—ERBB2—kidney cancer	2.21e-06	0.000117	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—ERBB2—kidney cancer	2.2e-06	0.000116	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—PIK3CA—kidney cancer	2.2e-06	0.000116	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—RAF1—kidney cancer	2.18e-06	0.000115	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—MAPK1—kidney cancer	2.18e-06	0.000115	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—PTEN—kidney cancer	2.18e-06	0.000115	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—MTOR—kidney cancer	2.18e-06	0.000115	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—RELA—kidney cancer	2.17e-06	0.000115	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—MTOR—kidney cancer	2.17e-06	0.000115	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—PTEN—kidney cancer	2.17e-06	0.000114	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—ERBB2—kidney cancer	2.16e-06	0.000114	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—PTGS2—kidney cancer	2.15e-06	0.000114	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—MTOR—kidney cancer	2.13e-06	0.000113	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—KRAS—kidney cancer	2.06e-06	0.000109	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—PTEN—kidney cancer	2.05e-06	0.000108	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—PIK3CA—kidney cancer	2.04e-06	0.000108	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—CDKN1B—kidney cancer	2.04e-06	0.000108	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—CDKN1B—kidney cancer	2.04e-06	0.000108	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—POMC—kidney cancer	2.03e-06	0.000107	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—RAF1—kidney cancer	2.03e-06	0.000107	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—RELA—kidney cancer	2.02e-06	0.000107	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—ERBB2—kidney cancer	2.01e-06	0.000106	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—CDKN1B—kidney cancer	2e-06	0.000106	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—IL2—kidney cancer	2e-06	0.000106	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—IL2—kidney cancer	1.99e-06	0.000105	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—MTOR—kidney cancer	1.98e-06	0.000105	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—VEGFA—kidney cancer	1.97e-06	0.000104	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—IL2—kidney cancer	1.96e-06	0.000103	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—VEGFA—kidney cancer	1.96e-06	0.000103	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—CCND1—kidney cancer	1.95e-06	0.000103	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—JUN—kidney cancer	1.94e-06	0.000103	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—CCND1—kidney cancer	1.94e-06	0.000103	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—JUN—kidney cancer	1.94e-06	0.000103	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—CTNNB1—kidney cancer	1.93e-06	0.000102	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—GSTP1—kidney cancer	1.93e-06	0.000102	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—CTNNB1—kidney cancer	1.93e-06	0.000102	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—POMC—kidney cancer	1.92e-06	0.000101	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—CCND1—kidney cancer	1.91e-06	0.000101	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—JUN—kidney cancer	1.9e-06	0.000101	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—PIK3CA—kidney cancer	1.89e-06	0.0001	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—CTNNB1—kidney cancer	1.89e-06	9.98e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—PTEN—kidney cancer	1.88e-06	9.94e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—PTEN—kidney cancer	1.88e-06	9.91e-05	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—PTEN—kidney cancer	1.88e-06	9.91e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—MAPK3—kidney cancer	1.86e-06	9.83e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—CDKN1B—kidney cancer	1.86e-06	9.82e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—MAPK3—kidney cancer	1.85e-06	9.78e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—PTEN—kidney cancer	1.84e-06	9.73e-05	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—TP53—kidney cancer	1.83e-06	9.68e-05	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—PIK3CA—kidney cancer	1.83e-06	9.67e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—ABCB1—kidney cancer	1.83e-06	9.65e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—IL2—kidney cancer	1.82e-06	9.61e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—MYC—kidney cancer	1.81e-06	9.56e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—MYC—kidney cancer	1.8e-06	9.51e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—GSTM1—kidney cancer	1.77e-06	9.37e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—CCND1—kidney cancer	1.77e-06	9.37e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—MAPK1—kidney cancer	1.77e-06	9.35e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—JUN—kidney cancer	1.77e-06	9.35e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—MAPK1—kidney cancer	1.76e-06	9.3e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—CTNNB1—kidney cancer	1.76e-06	9.27e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—PTEN—kidney cancer	1.71e-06	9.04e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—VEGFA—kidney cancer	1.7e-06	8.97e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—VEGFA—kidney cancer	1.7e-06	8.96e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—CYP1A1—kidney cancer	1.68e-06	8.88e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—KRAS—kidney cancer	1.67e-06	8.83e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—VEGFA—kidney cancer	1.66e-06	8.79e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—KRAS—kidney cancer	1.66e-06	8.79e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—PTGS2—kidney cancer	1.62e-06	8.57e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—MAPK3—kidney cancer	1.61e-06	8.49e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—MAPK3—kidney cancer	1.6e-06	8.47e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—MAPK3—kidney cancer	1.57e-06	8.31e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—MYC—kidney cancer	1.56e-06	8.26e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—MYC—kidney cancer	1.56e-06	8.24e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—VEGFA—kidney cancer	1.55e-06	8.16e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—PIK3CA—kidney cancer	1.54e-06	8.11e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—MYC—kidney cancer	1.53e-06	8.09e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—MAPK1—kidney cancer	1.53e-06	8.08e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—PTGS2—kidney cancer	1.53e-06	8.08e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—PIK3CA—kidney cancer	1.53e-06	8.07e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—MAPK1—kidney cancer	1.53e-06	8.06e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—MAPK1—kidney cancer	1.5e-06	7.91e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—TP53—kidney cancer	1.49e-06	7.85e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—TP53—kidney cancer	1.48e-06	7.81e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—MAPK3—kidney cancer	1.46e-06	7.72e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—KRAS—kidney cancer	1.44e-06	7.63e-05	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—PIK3CA—kidney cancer	1.44e-06	7.63e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—KRAS—kidney cancer	1.44e-06	7.61e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—MYC—kidney cancer	1.42e-06	7.51e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—PTEN—kidney cancer	1.42e-06	7.48e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—KRAS—kidney cancer	1.41e-06	7.47e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—MAPK1—kidney cancer	1.39e-06	7.35e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—PTEN—kidney cancer	1.33e-06	7.04e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—PIK3CA—kidney cancer	1.33e-06	7.01e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—PIK3CA—kidney cancer	1.32e-06	6.99e-05	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—PIK3CA—kidney cancer	1.32e-06	6.99e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—KRAS—kidney cancer	1.31e-06	6.94e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—PIK3CA—kidney cancer	1.3e-06	6.86e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—TP53—kidney cancer	1.28e-06	6.78e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—TP53—kidney cancer	1.28e-06	6.77e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—TP53—kidney cancer	1.26e-06	6.64e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—POMC—kidney cancer	1.25e-06	6.62e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—PIK3CA—kidney cancer	1.21e-06	6.38e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—TP53—kidney cancer	1.17e-06	6.17e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—PTGS2—kidney cancer	1e-06	5.28e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—PIK3CA—kidney cancer	9.98e-07	5.27e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—PIK3CA—kidney cancer	9.41e-07	4.97e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—PTEN—kidney cancer	8.72e-07	4.61e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—PIK3CA—kidney cancer	6.15e-07	3.25e-05	CbGpPWpGaD
